Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von conna 

Amgen Inc. diskutieren

Amgen Inc.

WKN: 867900 / Symbol: AMGN / Name: Amgen / Aktie / Biotechnologie & medizinische Forschung / Large Cap /

255,20 €
0,23 %

Einschätzung Buy
Rendite (%) -1,50 %
Kursziel 283,20
Veränderung
Endet am 20.10.24

Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Oppenheimer Holdings Inc. from $290.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,28 %
Kursziel 300,48
Veränderung
Endet am 02.11.24

Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $320.00 price target on the stock, up previously from $260.00.
Ratings data for AMGN provided by MarketBeat

Einschätzung Buy
Rendite (%) 5,71 %
Kursziel 291,23
Veränderung
Endet am 29.11.24

Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $320.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,45 %
Kursziel 297,31
Veränderung
Endet am 19.12.24

Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $326.00 price target on the stock, up previously from $286.00.
Ratings data for AMGN provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,02 %
Kursziel 291,04
Veränderung
Endet am 21.12.24

Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to a "buy" rating. They now have a $320.00 price target on the stock, up previously from $264.00.
Ratings data for AMGN provided by MarketBeat

Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for AMGN provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,25 %
Kursziel 322,00
Veränderung
Endet am 01.02.25

Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $350.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,16 %
Kursziel 324,87
Veränderung
Endet am 07.02.25

Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $313.00 to $350.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat

Einschätzung Buy
Rendite (%) -8,44 %
Kursziel 305,58
Veränderung
Endet am 07.02.25

Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $303.00 to $329.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,14 %
Kursziel 304,82
Veränderung
Endet am 03.04.25

Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $329.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,67 %
Kursziel 300,61
Veränderung
Endet am 12.04.25

Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $320.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,57 %
Kursziel 337,39
Veränderung
Endet am 18.04.25

Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at TD Cowen from $370.00 to $360.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat